Serotonin Receptors as Targets for Drugs Useful to Treat Psychosis and Cognitive Impairment in Schizophrenia

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1572-1586

Bentham Science Publishers

Access to resources Recommend Favorite

Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 144-152

Bentham Science Publishers

Access to resources Recommend Favorite

The Key Role of Medullary 5-HT3 Receptors in the Serotonin-Mediated Neural Control of Cardiovascular Function

By  

Current Neuropharmacology, Vol. 3, Iss. 3, 2005-07 ,pp. : 231-248

Bentham Science Publishers

Access to resources Recommend Favorite

Muscarinic Receptors as a Target for Drugs Treating Schizophrenia

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 163-181

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine Receptor Pharmacology: Interactions with Serotonin Receptors and Significance for the Aetiology and Treatment of Schizophrenia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 1, 2006-02 ,pp. : 3-23

Bentham Science Publishers

Access to resources Recommend Favorite